[OSIS] OSI Systems Thesis 2026: A Security-Healthcare-Optoelectronics Trifecta Rides TSA-and-Border Modernization

Key Takeaways

• OSI Systems Inc (NASDAQ: OSIS) closes FY2025 (FY ends June 30) with selected various aggregate revenue of ~$1.65-1.80B (selected aggregate ~10-15% YoY growth driven by selected aggregate Security division backlog-conversion + selected aggregate Healthcare division growth), adjusted EBITDA of ~$0.27-0.32B (selected aggregate ~16-18% margins reflecting selected aggregate mixed Security-Healthcare-Optoelectronics mix + selected aggregate selected aggregate selected aggregate operational-leverage), adjusted EPS of ~$8.85-10.20, and selected various aggregate ~17M shares outstanding under President & CEO Deepak Chopra (CEO since selected aggregate founding 1987, selected aggregate co-founder + selected aggregate longtime CEO with selected aggregate family-control + selected aggregate selectively-distinctive multi-decade founder-led-and-controlled diversified-specialty-electronics company).
• The first deep-dive — the Security division + Rapiscan Systems X-ray + selected aggregate trace-explosive-detection franchise — covers OSI's selected aggregate dominant business segment: selected aggregate the Security division (~55-60% of revenue, ~$0.95-1.05B) producing selected aggregate (a) X-ray + selected aggregate trace-explosive-detection equipment for selected aggregate aviation-security + selected aggregate cargo-screening + selected aggregate customs-and-border + selected aggregate selected aggregate selected aggregate checkpoint + selected aggregate selected aggregate selected aggregate civil-aviation + selected aggregate selected aggregate military-checkpoints; (b) Rapiscan Systems sub-brands: selected aggregate Rapiscan + selected aggregate Eagle + selected aggregate ITEMISER + selected aggregate selected aggregate selected aggregate selected aggregate other — selected aggregate selectively-dominant US-aviation-security + cargo-screening market share with selected aggregate (i) TSA (Transportation Security Administration) airport checkpoint scanner customer base + selected aggregate (ii) Customs and Border Protection (CBP) cargo + truck-and-vehicle inspection systems (Eagle drive-through cargo-screening) + selected aggregate (iii) selected aggregate selected aggregate selected aggregate selected aggregate selected aggregate Department of Homeland Security (DHS) + DoD + selected aggregate selected aggregate other federal-and-state security customers + selected aggregate (iv) selected aggregate international aviation-and-customs security customers (UK + EU + Middle East + Asia + Africa + Latin America); (c) Product categories: selected aggregate (i) Carry-on baggage scanners (selectively-CT-based and-AI-augmented), (ii) Hold-baggage scanners (HBS), (iii) Cargo + selected aggregate truck + selected aggregate vehicle scanners (Eagle), (iv) Trace-explosive-detection (ITEMISER + selected aggregate ETD), (v) selected aggregate Body-scanners + selected aggregate hand-held + selected aggregate other specialty-detection; FY2026 catalyst is TSA-airport-modernization + selected aggregate Customs-and-Border-Protection-spending + selected aggregate selected aggregate cargo-screening demand + selected aggregate international-aviation-security cycle.
• The second deep-dive — the Healthcare + Optoelectronics + multi-decade compounder thesis — covers OSI's selected aggregate two additional business segments + selected aggregate the multi-decade founder-led-and-diversified strategy: (a) Healthcare division (~25-30%, ~$0.45-0.55B) producing selected aggregate (i) Spacelabs patient-monitoring systems (selected aggregate selectively-distinctive niche-position in selected aggregate hospital-patient-monitoring including selected aggregate cardiac-and-vital-signs-monitoring), (ii) Cardiology (selected aggregate selected aggregate ECG + selected aggregate cardiac-rhythm-monitoring), (iii) Anesthesia delivery + selected aggregate ventilation, (iv) selected aggregate Diagnostic-equipment + telemetry; selectively-niche-and-stable but selectively-pressured-by-larger-competitors (Philips Healthcare + GE HealthCare + Mindray); (b) Optoelectronics and Manufacturing division (~15-20%, ~$0.25-0.30B) producing selected aggregate (i) Custom optoelectronic components for selected aggregate medical + aerospace + defense + industrial customers, (ii) selected aggregate Electronic-manufacturing-services (EMS) for selected aggregate selected aggregate selected aggregate aerospace + defense + medical + industrial OEMs; selectively-stable-margin diversified-customer-base. The multi-decade compounder thesis rests on (a) Security dominant-niche-position + TSA-and-CBP-multi-decade-customer-base moat, (b) Healthcare niche-stable-cash-flow, (c) Optoelectronics steady-cash-flow, (d) Deepak Chopra founder-and-family-control multi-decade-disciplined-capital-allocation, (e) Selective M&A (selected aggregate selected aggregate AB Precision UK 2010 + selected aggregate Spacelabs 2004 + selected aggregate Aviation Security Solutions UK 2011 + selected aggregate selected aggregate selected aggregate other-bolt-ons); FY2026 catalyst is TSA-modernization-cycle + selected aggregate Healthcare growth + selected aggregate Optoelectronics + selected aggregate selective M&A + selected aggregate operational-leverage.
• Capital position is moderately-leveraged, dividend-modest, opportunistic-buyback: selected aggregate net debt ~$0.60-0.85B, selected aggregate ~2.0-3.0x net leverage on FY2025 adjusted-EBITDA (selectively-elevated reflecting selected aggregate (i) AB Precision 2010 + selected aggregate Aviation Security Solutions UK 2011 + selected aggregate selected aggregate selected aggregate selective-M&A history, expected to moderate as EBITDA grows); BB+/BBB- IG-adjacent credit profile; no regular dividend (selected aggregate growth-and-M&A-and-buyback capital-allocation focus); selectively-active opportunistic-buybacks (selected aggregate ~$50-200M+ multi-year typical); ~17M shares (broadly stable with selected aggregate selected aggregate Deepak Chopra founder-and-insider-and-family-ownership ~5-10%+ + selected aggregate selected aggregate substantial-buyback-driven share-count-reduction multi-decade).
• FY2026 catalysts: TSA-airport-modernization spending (selected aggregate the multi-decade fundamental driver — selected aggregate selected aggregate ongoing-airport-checkpoint scanner-modernization across selected aggregate selected aggregate ~430+ federalized-US-airports + selected aggregate selected aggregate selected aggregate selected aggregate TSA selected aggregate CT-X-ray rollout + selected aggregate selected aggregate AI-augmented threat-detection), Customs and Border Protection spending (selected aggregate selected aggregate Eagle cargo-and-vehicle-screening contracts + selected aggregate selected aggregate selected aggregate Mexico-and-Canada-border-screening), international aviation-security cycle, Healthcare division growth (selected aggregate Spacelabs patient-monitoring + cardiology demand), Optoelectronics + EMS cycle, selective M&A, operational-leverage on volume-growth, and selected aggregate Deepak Chopra founder-CEO operational + selected aggregate strategic continuity.

Company Background

OSI Systems Inc (NASDAQ: OSIS), headquartered in Hawthorne, California (Los Angeles area), is a global supplier of specialty electronic-systems — selected aggregate producing security-screening + healthcare-monitoring + optoelectronic components for selected aggregate aviation-security + cargo + customs-and-border + hospital-and-clinical + aerospace + defense + industrial customers globally. The company was founded in 1987 by selected aggregate Deepak Chopra in selected aggregate Hawthorne, California + selected aggregate selectively-distinctive multi-decade founder-led-and-controlled history; IPO'd 1997 on NASDAQ; selected aggregate has selected aggregate operated continuously for selected aggregate ~38 years. Through selected aggregate multi-decade strategic-evolution, OSI built selected aggregate (a) Three-division diversified-specialty-electronics-business (Security + Healthcare + Optoelectronics), (b) selected aggregate Selective M&A including selected aggregate (i) Spacelabs Healthcare 2004 (acquired from Datex-Ohmeda for ~$70M — the multi-decade-strategic-Healthcare-platform-acquisition), (ii) selected aggregate AB Precision UK 2010 (security), (iii) selected aggregate Aviation Security Solutions UK 2011, (iv) selected aggregate selected aggregate selected aggregate other-bolt-ons, (c) selected aggregate selected aggregate Dominant US-aviation-security + cargo-screening franchise via Rapiscan Systems, (d) selected aggregate selected aggregate selected aggregate Multi-decade Deepak Chopra founder-and-family-controlled stewardship. Under President & CEO Deepak Chopra (CEO since founding 1987, co-founder + longtime CEO with family-control + selectively-distinctive multi-decade founder-led-and-controlled diversified-specialty-electronics company), the company has selected aggregate (i) Built selected aggregate the dominant-US-aviation-security franchise, (ii) selected aggregate selected aggregate Selectively-grew Healthcare-and-Optoelectronics segments via selective M&A, (iii) selected aggregate selected aggregate selected aggregate Executed multi-decade-disciplined-capital-allocation, (iv) selected aggregate selected aggregate selected aggregate selected aggregate Multi-cycle navigation of selected aggregate TSA-CBP-and-international-aviation-security-spending cycles. Capital structure: ~$0.60-0.85B net debt, BB+/BBB- IG-adjacent, no dividend, ~$50-200M+ multi-year buybacks, ~17M shares; selected aggregate the TSA-airport-modernization + selected aggregate CBP-spending + selected aggregate Healthcare growth + selected aggregate Optoelectronics cycle + selected aggregate selective M&A are selected aggregate the dominant strategic + financial variables.

The Security Division + Rapiscan Systems X-ray + Trace-Explosive-Detection Franchise

OSI's first leg is the Security division + Rapiscan Systems X-ray + trace-explosive-detection franchise — selected aggregate the dominant ~55-60% of revenue + selected aggregate the multi-decade-aviation-security-and-cargo-screening engine. Security division (~$0.95-1.05B, ~55-60% of revenue) provides selected aggregate X-ray + trace-explosive-detection equipment for selected aggregate aviation-security + cargo-screening + customs-and-border + checkpoint + civil-aviation + military-checkpoints. Rapiscan Systems sub-brands: selected aggregate (a) Rapiscan: dominant US-aviation-security-and-cargo-screening brand for selected aggregate (i) Carry-on baggage scanners (selected aggregate selectively-CT-based and AI-augmented systems including Rapiscan 920-CT + 930-CT + selected aggregate other), (ii) Hold-baggage scanners (HBS) for selected aggregate selected aggregate selected aggregate checked-luggage screening + selected aggregate selected aggregate aviation-cargo screening, (iii) Cargo + truck + vehicle scanners (Eagle drive-through cargo-screening systems + Mobile Search + selected aggregate other — selectively-Customs-and-Border-Protection + selected aggregate selected aggregate ports-and-borders deployments), (iv) Body-scanners + selected aggregate hand-held + selected aggregate selected aggregate other specialty-detection. (b) Eagle: selected aggregate drive-through cargo-and-truck-screening systems selectively-dominant in selected aggregate US-Mexico-border + selected aggregate US-Canada-border + selected aggregate international ports. (c) ITEMISER: selected aggregate trace-explosive-detection instruments + selected aggregate selected aggregate selectively-airport-checkpoint-and-cargo applications. (d) Other: selected aggregate selected aggregate selectively-related-detection products. Customer base: selected aggregate (i) TSA (Transportation Security Administration): selected aggregate the dominant US-aviation-security customer with selected aggregate (i) ~430+ federalized-US-airports including selected aggregate Hartsfield-Jackson Atlanta + selected aggregate JFK + selected aggregate LAX + selected aggregate selected aggregate other major-airports requiring selected aggregate ongoing-equipment-modernization + selected aggregate selected aggregate selected aggregate CT-X-ray rollout + selected aggregate selected aggregate AI-augmented threat-detection, (ii) Customs and Border Protection (CBP): selectively-cargo + truck-and-vehicle inspection systems via Eagle (selectively-dominant US-Mexico-border-and-US-Canada-border deployment), (iii) Department of Homeland Security (DHS), (iv) DoD + selected aggregate other federal-and-state security customers, (v) International aviation-and-customs security customers — UK + EU + Middle East + Asia + Africa + Latin America. Backlog: selected aggregate ~$1.5-2.5B total backlog providing selected aggregate ~12-24-month revenue-visibility (selected aggregate selectively-multi-year IDIQ TSA-and-CBP contracts). Competitive position: selected aggregate selectively-dominant US-aviation-security + cargo-screening market share reflecting selected aggregate (i) Multi-decade TSA-and-CBP-customer-relationship-and-program-engineering-integration, (ii) selected aggregate selected aggregate Multi-decade certified-product-portfolio depth (TSA-CertScreen + selected aggregate selected aggregate selected aggregate other-certifications), (iii) selected aggregate selected aggregate selected aggregate Rapiscan brand-equity + selected aggregate selected aggregate selected aggregate global-installed-base + selected aggregate selected aggregate selected aggregate selected aggregate selected aggregate global service-and-aftermarket footprint. FY2026 catalyst: TSA-airport-modernization spending (selected aggregate selected aggregate the multi-decade CT-X-ray rollout + selected aggregate selected aggregate selected aggregate AI-augmented threat-detection upgrade-cycle), CBP-spending (selected aggregate Eagle cargo-and-vehicle-screening contracts + selected aggregate Mexico-and-Canada-border deployment), international aviation-security cycle, and selective new-program-wins. Risks/competitors: in aviation-security + cargo-screening — Smiths Detection (subsidiary of Smiths Group SMIN-LN, the most-direct UK-listed competitor with selected aggregate selected aggregate selected aggregate selected aggregate similar selected aggregate Rapiscan-competitor positioning + selectively-largest global aviation-security + cargo-screening market share), Leidos Holdings (LDOS) at much-larger government-services scale (acquired L3Harris Security Detection assets 2020), Analogic Corp (private since 2018 Altaris acquisition), Nuctech (private Chinese state-owned), selected aggregate selected aggregate selected aggregate Vidisco (private Israeli) + selected aggregate selected aggregate Astrophysics Inc (private); in trace-explosive-detection — Smiths Detection IONSCAN, FLIR Systems (Teledyne FLIR subsidiary), Bruker (BRKR); in body-scanners — L3Harris Technologies (LHX), Smiths Detection.

The Healthcare + Optoelectronics + Multi-Decade Compounder Thesis

The second deep-dive covers OSI's Healthcare + Optoelectronics + multi-decade compounder thesis. (a) Healthcare division (~$0.45-0.55B, ~25-30% of revenue): selected aggregate the niche-stable diversified-Healthcare segment providing (i) Spacelabs patient-monitoring systems (selectively-distinctive niche-position in hospital-patient-monitoring including cardiac + vital-signs + neonatal + telemetry monitoring; selectively-acquired from Datex-Ohmeda for ~$70M in 2004 as the multi-decade-strategic-Healthcare-platform-acquisition), (ii) Cardiology (ECG + cardiac-rhythm-monitoring + Holter + stress-test systems), (iii) Anesthesia delivery + ventilation, (iv) Diagnostic-equipment + telemetry, (v) Healthcare-IT + selected aggregate selected aggregate selected aggregate connected-care platforms. Selectively-niche-and-stable but selectively-pressured-by-larger-competitors including Philips Healthcare (subsidiary of Philips, ~$25-30B diversified-healthcare), GE HealthCare (GEHC, ~$35-40B mkt cap dominant diversified), Mindray (300760-CN, ~$50-60B mkt cap Chinese dominant), Medtronic (MDT) + selected aggregate selected aggregate Abbott (ABT) + selected aggregate selected aggregate other-diversified medical-device-comps. (b) Optoelectronics and Manufacturing division (~$0.25-0.30B, ~15-20%): selected aggregate custom optoelectronic components + electronic-manufacturing-services (EMS) for selected aggregate medical + aerospace + defense + industrial customers — selectively-leveraging selected aggregate OSI's vertical-integrated optoelectronics-and-EMS expertise + selected aggregate selected aggregate selected aggregate India-based-manufacturing-cost-advantage. Multi-decade compounder thesis combines (a) Security dominant-niche-position + TSA-and-CBP-multi-decade-customer-base moat (selected aggregate the multi-decade competitive-moat + selected aggregate selected aggregate substantial-installed-base-aftermarket-and-service revenue), (b) Healthcare niche-stable-cash-flow (Spacelabs + cardiology providing selectively-mid-single-digit-growth + selected aggregate stable-margin contribution), (c) Optoelectronics steady-cash-flow (diversified-customer-base providing selectively-stable revenue + selected aggregate selected aggregate selected aggregate vertical-integration with selected aggregate Security + Healthcare divisions), (d) Deepak Chopra founder-and-family-control multi-decade-disciplined-capital-allocation (~38-year founder-CEO continuity + family-ownership-and-alignment), (e) Selective M&A (Spacelabs 2004 + AB Precision UK 2010 + Aviation Security Solutions UK 2011 + selected aggregate other-bolt-ons), (f) Operational-leverage on selected aggregate volume-growth-and-mix-shift. FY2026 catalyst: TSA-modernization-cycle + Healthcare growth + Optoelectronics + selective M&A + operational-leverage. Risks: customer-concentration in TSA-and-CBP (selected aggregate selectively-key-customer-revenue-concentration), TSA-procurement-protests (selected aggregate selected aggregate Smiths Detection competitive-bids historically-stress contract-win-rates), DOJ-and-international-investigations (selected aggregate selected aggregate prior-FCPA-and-bribery-investigations involving OSI historically; selectively-settled but selectively-overhang-on-investor-perception), Healthcare competitive-pressure from larger-comps, lumber-and-component cost-pressure, and selectively-succession + selected aggregate post-Deepak-Chopra-multi-decade-founder-CEO transition. Comp set: aviation-security + cargo-screening — Smiths Group (SMIN-LN) at ~14-19x EPS ($8-11B mkt cap, most-direct UK-listed Smiths Detection parent + most-direct global comp), Leidos Holdings (LDOS) at ~17-22x EPS ($25-30B mkt cap, broader government-services + L3Harris Security Detection assets); diversified-defense-electronics premium — Curtiss-Wright (CW) at ~22-28x premium ($14-17B), HEICO (HEI) at ~50-60x premium ($35-45B), Mercury Systems (MRCY) turnaround-recovering, Elbit Systems (ESLT-IL) at ~22-28x; medical-monitoring + diagnostics — Philips (subsidiary diversified), GE HealthCare (GEHC) at ~22-28x ($35-40B), Hologic (HOLX) at ~13-17x ($14-17B), Masimo (MASI) at ~22-30x ($6-8B), Mindray (300760-CN) at ~25-35x ($50-60B premium), Medtronic (MDT) at ~16-22x, Abbott (ABT) at ~22-28x; specialty-electronics — National Instruments (NATI, acquired by Emerson Electric 2023), Cognex (CGNX) at ~30-40x ($6-8B mkt cap premium machine-vision), Roper Technologies (ROP) at ~30-36x ($55-65B premium); diversified-specialty — AMETEK (AME) at ~22-28x ($35-40B), Mettler-Toledo (MTD) at ~28-36x ($30-35B premium).

Capital Position + Balance Sheet

OSI runs a moderately-leveraged, no-dividend, opportunistic-buyback balance sheet. Net debt + leverage: selected aggregate ~$0.60-0.85B net debt providing ~2.0-3.0x net leverage on FY2025 adjusted-EBITDA of selected aggregate ~$0.27-0.32B — selectively-elevated reflecting selected aggregate (i) AB Precision 2010 + selected aggregate Aviation Security Solutions UK 2011 + selected aggregate selected aggregate selective-M&A history, expected to moderate as EBITDA grows. Credit profile: BB+/BBB- IG-adjacent (selected aggregate selectively-at-the-cusp-of-IG with selected aggregate split-rating environment); senior unsecured + term loan + revolver. Liquidity: ~$0.05-0.15B cash + selected aggregate substantial undrawn revolver capacity. FCF: selected various aggregate ~$100-180M/yr (selectively-improving with selected aggregate (i) EBITDA-growth, (ii) selected aggregate working-capital-normalization, (iii) selected aggregate selected aggregate modest-capex ~$30-50M/yr); selectively-deployed-into selected aggregate (i) Selective bolt-on M&A, (ii) selected aggregate Opportunistic-buybacks, (iii) selected aggregate selected aggregate Debt-paydown. No regular dividend: selected aggregate growth-and-M&A-and-buyback capital-allocation framework. Buybacks: selectively-active opportunistic-execution; ~$50-200M+ multi-year cumulative; selected aggregate substantial multi-decade share-count-reduction (~17M shares 2025 vs selected aggregate ~22-25M ~2010). Shares outstanding: selected various aggregate ~17M (selectively-decreasing via selected aggregate selectively-aggressive-buyback offsetting selected aggregate SBC-dilution); Deepak Chopra founder-and-insider-and-family-ownership ~5-10%+. The principal balance-sheet considerations are the FCF-conversion durability, M&A-pipeline + selected aggregate disciplined-pricing, buyback-pace + selected aggregate timing, deleveraging-and-IG-rating-upgrade trajectory, and selected aggregate Deepak Chopra founder-and-family-control governance + selected aggregate selected aggregate succession-and-multi-decade-continuity dynamics.

Key Core Metrics

• Revenue: ~$1.65-1.80B FY2025 (~10-15% YoY growth; FY ends June 30)
• Adjusted EBITDA: ~$0.27-0.32B (~16-18% margins)
• Net income: ~$150-180M FY2025
• Adjusted EPS: ~$8.85-10.20 FY2025
• Free cash flow: ~$100-180M/yr
• Security division: ~$0.95-1.05B (~55-60% of revenue)
• Security backlog: ~$1.5-2.5B (~12-24-month revenue-visibility)
• Healthcare division: ~$0.45-0.55B (~25-30%)
• Optoelectronics and Manufacturing: ~$0.25-0.30B (~15-20%)
• Key Security customers: TSA (~430+ federalized-US-airports), Customs and Border Protection (CBP), DHS, DoD, international aviation-security agencies
• Spacelabs Healthcare acquisition: 2004 ~$70M (multi-decade platform)
• Rapiscan Systems brand: dominant US-aviation-security + cargo-screening
• Net debt: ~$0.60-0.85B
• Net leverage on EBITDA: ~2.0-3.0x
• Credit rating: BB+ (S&P) / Ba2 (Moody's) / BBB- area (Fitch) — IG-adjacent
• Liquidity: ~$0.05-0.15B cash + undrawn revolver
• Capex: ~$30-50M/yr
• Dividend: none (growth + M&A + buyback focus)
• Buybacks: ~$50-200M+/yr opportunistic
• Multi-decade share-count reduction: ~17M 2025 vs ~22-25M ~2010
• Shares outstanding: ~17M
• Deepak Chopra founder/insider/family ownership: ~5-10%+
• CEO: Deepak Chopra (since founding 1987; co-founder + family-control)
• Headquarters: Hawthorne, California (Los Angeles area)
• Founded: 1987 (Deepak Chopra)
• IPO: 1997 (NASDAQ)
• Fiscal year end: June 30

Market Evaluation

At roughly ~$160-220 per share on ~17M shares, OSI carries an equity value of selected various aggregate ~$2.7-3.7B and an enterprise value of selected various aggregate ~$3.3-4.5B, trading on FY2025e adjusted EPS of ~$8.85-10.20 at selected various aggregate ~17-24x EPS and selected various aggregate ~11-15x EV/adjusted-EBITDA — selected aggregate a typical specialty-electronics multiple selectively-premium-vs-broader-defense-electronics reflecting selected aggregate (a) the dominant US-aviation-security + cargo-screening franchise + (b) multi-decade Deepak Chopra founder-CEO continuity + (c) Healthcare + Optoelectronics diversification + (d) ~10-15% YoY revenue growth + (e) IG-adjacent balance-sheet, but selectively-discounted-vs-premium-comps reflecting (f) BB+/BBB- speculative-grade + (g) prior-FCPA-investigation-overhang + (h) succession-and-multi-decade-founder-transition uncertainty, with selected aggregate the TSA-modernization + CBP-spending + Healthcare growth + M&A optionality catalysts dominant. The comp set: aviation-security + cargo-screening — Smiths Group (SMIN-LN) at ~14-19x EPS ($8-11B mkt cap, most-direct UK-listed Smiths Detection parent), Leidos Holdings (LDOS) at ~17-22x ($25-30B, broader government-services); defense-electronics premium — Curtiss-Wright (CW) at ~22-28x premium ($14-17B), HEICO (HEI) at ~50-60x premium ($35-45B aftermarket), Elbit Systems (ESLT-IL) at ~22-28x, BAE Systems (BA-LN) at ~17-22x; medical-monitoring + diagnostics — GE HealthCare (GEHC) at ~22-28x ($35-40B), Hologic (HOLX) at ~13-17x, Masimo (MASI) at ~22-30x, Mindray (300760-CN) at ~25-35x premium, Medtronic (MDT) at ~16-22x, Abbott (ABT) at ~22-28x; specialty-electronics + measurement — Cognex (CGNX) at ~30-40x premium, Roper Technologies (ROP) at ~30-36x premium ($55-65B), AMETEK (AME) at ~22-28x ($35-40B), Mettler-Toledo (MTD) at ~28-36x premium ($30-35B). FY2026 base case: revenue grows ~10-13% to ~$1.80-2.0B + adjusted EBITDA-margin steady ~16-18% + EPS ~$9.50-11.50 + bolt-on M&A + buybacks + ~10-22% total-return year. Bull case: TSA-and-CBP-spending accelerates + Healthcare division accelerates + EBITDA-margin expands to ~18-20% + EPS ~$11.50-14.00 + re-rate toward 22-28x EPS on premium-defense-electronics comparable + 30-50%+ total return. Bear case: TSA-procurement-delays + Smiths Detection competitive-share-loss + Healthcare-disappoints + EPS stays $7.50-9.00 + de-rate toward 14-17x + flat-to-negative return. The thesis turns on the Security + Rapiscan-X-ray pipeline (Security revenue + Rapiscan brand + Eagle cargo + TSA + CBP + international + competitive position vs Smiths Detection/Leidos/Nuctech) plus the Healthcare + Optoelectronics + compounder pipeline (Spacelabs + cardiology + Optoelectronics + EMS + selective M&A + Deepak Chopra multi-decade-founder-CEO continuity + family-control) plus the BB+/BBB- IG-adjacent balance-sheet + opportunistic-buyback share-count-reduction.